Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Baylor Scott & White Medical Center - Temple located at 2401 S 31St St, Temple, TX, 76508 & includes data from NPIs 1013973403, 1598720211, 1477516466
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for Baylor Scott & White Medical Center - Temple compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,394 | 2,265 | ||||||||||
| Surgical | 795 | 767 | ||||||||||
| Non Surgical | 1,599 | 1,498 | ||||||||||
| Cardiovascular | 457 | 430 | ||||||||||
| General Medicine | 358 | 313 | ||||||||||
| Orthopedics | 280 | 277 | ||||||||||
| Gastroenterology & Endocrinology | 242 | 237 | ||||||||||
| General Surgery | 240 | 222 | ||||||||||
| Pulmonology | 220 | 210 | ||||||||||
| Urology | 205 | 203 | ||||||||||
| Neurology | 184 | 172 | ||||||||||
| Oncology & Hematology | 62 | 59 | ||||||||||
| Psychiatry & Mental Disorders | 43 | 41 | ||||||||||
| Colorectal | 36 | 35 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 26 | 25 | ||||||||||
| Obstetrics & Gynecology | 21 | 21 | ||||||||||
| Dermatology | 11 | 11 |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Hypertension | ||||||||||||
| Coronary Bypass | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Endocrine Disorders | ||||||||||||
| Cholecystectomy |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||
| DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Trauma | ||||||||||||
| Pulmonary Embolism |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Texas Total Hospitalizations (Jan 2019 to Mar 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Avg. LOS | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procedures For Obesity | ||||||||||||
| Stomach, Esophageal And Duodenal Procedures |